Libbs Ventures

Libbs Ventures operates as the dedicated corporate venturing arm of Libbs Farmacêutica, a prominent Brazilian pharmaceutical company. It primarily functions through an open innovation program, notably known as Linna, which actively identifies and partners with startups and scale-ups. This initiative focuses on leveraging external technological advancements and novel approaches to develop comprehensive solutions across various therapeutic areas, enhancing the parent company's robust pharmaceutical portfolio.

Libbs Farmacêutica, a privately held entity, established its operations in 1958. The insight driving the creation of Libbs Ventures stemmed from a strategic understanding of the need to integrate external innovation with internal research and development. This approach allows the company to accelerate its impact in the healthcare sector by tapping into a broader ecosystem of emerging technologies and entrepreneurial talent, reflecting a forward-thinking evolution in its long-standing history.

The program engages with a diverse range of innovative companies, seeking to co-create and implement solutions that ultimately benefit patients, caregivers, and healthcare professionals. Libbs Ventures aligns with the parent company’s mission to produce innovative pharmaceutical solutions and inspire a community committed to health. Its long-term vision involves continuously exploring new frontiers in healthcare, aiming to introduce impactful advancements that address unmet medical needs.